Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance study of [14C]-KBP-5074 in healthy males
NCT04634812Phase 1Completed
- Sponsor
- KBP Biosciences
- Start
- Dec 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ocederenone, sponsored by KBP Biosciences. Primary endpoints: Mass Balance of KBP-5074 at 240 hours, Area Under the Concentration-Time Curve from Time 0 to Infinity at 216 hours and 2 more. Started Dec 2020; status: completed.
02
Drugs
ocederenone
Beyond the preview
Go deeper on NCT04634812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04634812.